Edward John Allera is a shareholder at Buchanan Ingersoll & Rooney and is co-chair of the firm’s FDA group, counseling clients on new product development and business opportunities in the areas of pharmaceuticals, hi-tech products, medical devices, food and cosmetics.
Ed has devoted his entire career to health care, as both a pharmacist and an attorney. He began his career at the Food and Drug Administration (FDA), where he served as associate chief counsel. Because of his ability to integrate science and the law, Ed has become highly-respected by clients in the pharma/biotech industry as the person to call in a “make-or-break” situation.
Ed’s expertise has also been recognized at the highest levels within the industry, including his recent appointment to the board of the FDA’s Reagan-Udall Foundation, the highly regarded not-for-profit created by Congress to advance regulatory science and technology in support of the FDA’s mission. As a board member, Ed joins a high-profile list of life sciences leaders including former FDA Commissioners, global biotech executives and CMS health policy administrators.
Ed has been selected by his peers for inclusion in The Best Lawyers in America© since 2021 in the area of FDA Law. Additionally, Ed was recognized as a leading Healthcare: Pharmaceutical/ Medical Products Regulatory lawyer in Washington, DC by Chambers USA in 2022.